On this page:OverviewPublicationsKey papers
ScholarIQanswers from OpenAlex & ORCID

Jay S. Skyler

ResearcherPublications, citations & collaboration network

Jay S. Skyler is a researcher indexed in ScholarIQ from OpenAlex & ORCID.

How many works does Jay S. Skyler have?

ScholarIQindexed works

Jay S. Skyler has 472 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Jay S. Skyler have?

ScholarIQcitation count

Jay S. Skyler has 25,795 citations in the OpenAlex counts ScholarIQ stores.

What is the h-index of Jay S. Skyler?

ScholarIQh-index

Jay S. Skyler has an h-index of 76 in OpenAlex.

What is the i10-index of Jay S. Skyler?

ScholarIQi10-index

Jay S. Skyler has an i10-index of 228 in OpenAlex.

What is the ORCID of Jay S. Skyler?

ScholarIQorcid

The ORCID for Jay S. Skyler is on the source record.

What is the OpenAlex record for Jay S. Skyler?

ScholarIQopenalex

The OpenAlex for Jay S. Skyler is on the source record.

What are the most-cited papers on Jay S. Skyler?

ScholarIQmost cited works
Staging Presymptomatic Type 1 Diabetes: A Scientific Statement of JDRF, the Endocrine Society, and the American Diabetes Association
Richard A. Insel, Jessica L. Dunne, Mark A. Atkinson, Jane L. Chiang, Dana Dabelea, Peter A. Gottlieb, Carla J. Greenbaum, Kevan C. Herold, Jeffrey P. Krischer, Åke Lernmark, Robert E. Ratner, Marian Rewers, Desmond Schatz, Jay S. Skyler, Jay M. Sosenko, Anette‐G. Ziegler
Diabetes Care. 20151,174 CitationsOPEN ACCESS
An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes
Kevan C. Herold, Brian N. Bundy, S. Alice Long, Jeffrey A. Bluestone, Linda A. DiMeglio, Matthew J. Dufort, Stephen E. Gitelman, Peter A. Gottlieb, Jeffrey P. Krischer, Peter S. Linsley, Jennifer B. Marks, Wayne D. Moore, Antoinette Moran, Henry Rodriguez, William E. Russell, Desmond Schatz, Jay S. Skyler, Eva Tsalikian, Diane K. Wherrett, Anette-Gabriele Ziegler, Carla J. Greenbaum
New England Journal of Medicine. 20191,141 CitationsOPEN ACCESS
Rituximab, B-Lymphocyte Depletion, and Preservation of Beta-Cell Function
Mark D. Pescovitz, Carla J. Greenbaum, Heidi Krause‐Steinrauf, Dorothy J. Becker, Stephen E. Gitelman, Robin Goland, Peter A. Gottlieb, Jennifer B. Marks, Paula McGee, Antoinette Moran, Philip Raskin, Henry Rodriguez, Desmond Schatz, Diane K. Wherrett, Darrell M. Wilson, John M. Lachin, Jay S. Skyler
New England Journal of Medicine. 20091,079 CitationsOPEN ACCESS
Practical recommendations for the management of diabetes in patients with COVID-19
Stefan R. Bornstein, Francesco Rubino, Kamlesh Khunti, Geltrude Mingrone, David Hopkins, Andreas L. Birkenfeld, Bernhard O. Boehm, Stephanie A. Amiel, Richard I. G. Holt, Jay S. Skyler, J. Hans DeVries, Éric Renard, Robert H. Eckel, Paul Zimmet, K. G. M. M. Alberti, Josép Vidal, Bruno Geloneze, Juliana C.N. Chan, Linong Ji, Barbara Ludwig
The Lancet Diabetes & Endocrinology. 2020995 CitationsOPEN ACCESS
Intensive Glycemic Control and the Prevention of Cardiovascular Events: Implications of the ACCORD, ADVANCE, and VA Diabetes Trials
Jay S. Skyler, Richard M. Bergenstal, Robert O. Bonow, John B. Buse, Prakash Deedwania, Edwin Gale, Barbara V. Howard, M. Sue Kirkman, Mikhail Kosiborod, Peter D. Reaven, Robert S. Sherwin
Diabetes Care. 2008886 CitationsOPEN ACCESS

Related on ScholarIQ

470M+ articles · 14-day free trial